Literature DB >> 25248885

A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma.

Tanuja Shet1, Poonam Panjwani, Sridhar Epari, Manju Sengar, Maya Prasad, Brijesh Arora, Siddhartha Laskar, Sumeet Gujral, Hari Menon, Shripad Banavali.   

Abstract

This study sought to quantify variant patterns in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) using a three tier scoring system assessing five parameters, namely: (a) percentage of nodularity scored from 100 % to < 75%, (b) T cell rich areas (< 20% to > 50%), (c) type of nodules, (d) dendritic network, intact or lost, and (e) extranodular distribution of lymphocyte predominant cells (< 15% to > 50%), with final scores from 0 to 10. In the 72 patients assessed, the 5-year disease-free survival (DFS) in patients with score ≤ 6 was 92% vs. 20% in those with scores > 6. The 5-year overall survival was 100% in patients with scores ≤ 6 and 87% in those with scores > 6. In the multivariate Cox regression analysis, scores > 6 and stage impacted DFS. This scoring system was effective in stratifying patients with NLPHL with variant patterns and could be used for the management of patients.

Entities:  

Keywords:  Nodular lymphocyte predominant Hodgkin lymphoma; disease outcome; histology; scoring; variant pattern

Mesh:

Year:  2014        PMID: 25248885     DOI: 10.3109/10428194.2014.961013

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group.

Authors:  D A Eichenauer; H Goergen; A Plütschow; D Wongso; K Behringer; S Kreissl; I Thielen; T Halbsguth; P J Bröckelmann; M Fuchs; B Böll; B von Tresckow; P Borchmann; A Engert
Journal:  Leukemia       Date:  2015-11-20       Impact factor: 11.528

2.  Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group.

Authors:  Ramona Vesna Untanu; Jason Back; Burton Appel; Qinglin Pei; Lu Chen; Allen Buxton; David C Hodgson; Peter F Ehrlich; Louis S Constine; Cindy L Schwartz; Robert E Hutchison
Journal:  Pediatr Blood Cancer       Date:  2017-08-12       Impact factor: 3.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.